Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early‐stage luminal breast cancer

AIMS: Phosphohistone H3 (PhH3) has been proposed as a novel proliferation marker in breast cancer. This study compares the interobserver agreement for assessment of the mitotic activity index (MAI), Ki67 expression, and PhH3 in a cohort of oestrogen receptor (ER)‐positive breast cancer patients. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: van Steenhoven, Julia E C, Kuijer, Anne, Kornegoor, Robert, van Leeuwen, Gijs, van Gorp, Joost, van Dalen, Thijs, van Diest, Paul J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539961/
https://www.ncbi.nlm.nih.gov/pubmed/32557844
http://dx.doi.org/10.1111/his.14185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539961/
https://www.ncbi.nlm.nih.gov/pubmed/32557844
http://dx.doi.org/10.1111/his.14185

Ejemplares similares